Slingshot members are tracking this event:
Arrowhead Pharma (ARWR) Likely to Announce New Data from Ongoing Phase 2 Studies of ARC-520 in Hepatitis-B in 2016
Slingshot Insights Explained
Apr 13, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 2 Data, Arc-520, Hepatitis-b, 2016